STAT+: Pharmalittle: We’re reading about a Novartis heart drug, BIO fighting a Trump program, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the usual routine of online meetings, phone calls, and deadlines has returned. You knew this would happen, yes? So to…

Read the full story at STAT ↗